Sign in

CIK 0001674632

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Beta Bionics, Inc.

Sign in to watch
Ticker
BBNX
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
475386878
Phone
+1 949-427-7785
Business address
11 HUGHES, IRVINE, CA, 92618
Former names
Beta Bionics, Inc
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$3,298,305
in 21 filings, $2.6M under 10b5-1 plans

Net −$3,298,305. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-11-16 Hopman Mark Chief Commercial Officer Exercise or conversion 10b5-1 +775 $5.10 $4K 54,918
2026-11-16 Hopman Mark Chief Commercial Officer Sale 10b5-1 −775 $16.22 $13K 54,143
2026-11-16 Hopman Mark Chief Commercial Officer Exercise or conversion · Employee Stock Option (right to buy) 10b5-1 −775 20,950
2026-11-02 Hopman Mark Chief Commercial Officer Sale 10b5-1 −370 $16.90 $6K 54,143
2026-10-26 Hopman Mark Chief Commercial Officer Sale 10b5-1 −821 $20.00 $16K 54,513
2026-10-14 Hopman Mark Chief Commercial Officer Sale −775 $17.35 $13K 55,334
2026-10-01 Hopman Mark Chief Commercial Officer Sale −370 $18.96 $7K 56,109
2026-09-16 Hopman Mark Chief Commercial Officer Sale 10b5-1 −30,779 $20.13 $620K 56,479
2026-09-14 Hopman Mark Chief Commercial Officer Sale 10b5-1 −775 $15.52 $12K 86,382
2026-09-09 Hopman Mark Chief Commercial Officer Sale 10b5-1 −35,994 $18.46 $665K 88,033
2026-09-09 Hopman Mark Chief Commercial Officer Sale 10b5-1 −36,870 $18.46 $681K 87,157
2026-09-02 Hopman Mark Chief Commercial Officer Sale −5,327 $19.11 $102K 124,027
2026-06-24 Hopman Mark Chief Commercial Officer Sale 10b5-1 −1,258 $15.01 $19K 129,354
2026-06-04 Hopman Mark Chief Commercial Officer Sale 10b5-1 −275 $12.31 $3K 130,612
2026-06-02 Hopman Mark Chief Commercial Officer Sale −5,329 $12.61 $67K 130,887
2026-03-04 Hopman Mark Chief Commercial Officer Sale 10b5-1 −353 $11.57 $4K 139,133
2026-03-02 Hopman Mark Chief Commercial Officer Sale −834 $12.36 $10K 139,486
2026-02-27 Hopman Mark Chief Commercial Officer Grant or award · Employee Stock Option (right to buy) +91,520 91,520
2026-02-27 Hopman Mark Chief Commercial Officer Grant or award +109,105 140,320
2026-02-27 Hopman Mark Chief Commercial Officer Grant or award · Employee Stock Option (right to buy) +58,749 58,749

Page 1 of 3 · 45 trades